ARTICLE | Financial News
Atlas closes $280M life sciences-only fund
April 18, 2015 12:53 AM UTC
Atlas Venture closed its oversubscribed $280 million Atlas Fund X, the firm's first fund since becoming an exclusively life sciences-focused VC.
Formerly a hybrid firm, Atlas separated its tech and life sciences teams last October, citing diverging ecosystems and business models. The healthcare team retained the Atlas name (see BioCentury, Oct. 6, 2014). ...